The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases

Last updated: July 9, 2024
Sponsor: Centre Hospitalier Universitaire, Amiens
Overall Status: Active - Recruiting

Phase

N/A

Condition

Collagen Vascular Diseases

Connective Tissue Diseases

Treatment

N/A

Clinical Study ID

NCT06054373
PI2023_843_0116
  • Ages > 18
  • All Genders

Study Summary

Polyclonal hypergammaglobulinaemia is characterized by increased levels of immunoglobulins and is a common feature observed in various diseases such as autoimmune diseases, chronic infectious diseases or lymphoid hemopathy. Some autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis or Sjögren's syndrome are frequently associated with polyclonal hypergammaglobulinaemia. Recent data have suggested that the distribution of immunoglobulin isotypes in polyclonal hypergammaglobulinaemia may be disease-specific. However, isotype repartition in polyclonal hypergammaglobulinaemia remains poorly understood.

The investigators will investigate the distribution of immunoglobulin isotype in patients with autoimmune disease and polyclonal hypergammaglobulinaemia. Moreover, the investigators will evaluate the isotype repartition as predictor of lymphoma or monoclonal gammopathy among patients with autoimmune diseases.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All adult patients > 18 years old

  • patients with one of the following diseases: systemic lupus erythematosus,rheumatoid arthritis, Sjögren's syndrome, autoimmune hepatitis, sarcoidosis orlymphoma.

Exclusion

Exclusion Criteria:

  • Age < 18 years;

  • chronic viral hepatitis;

  • HIV infection, syphilis,

  • tuberculosis

Study Design

Total Participants: 150
Study Start date:
July 27, 2023
Estimated Completion Date:
September 30, 2024

Connect with a study center

  • CHU Amiens

    Amiens, 80054
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.